Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial
To access this article, please choose from the options below
Clinical trial registration information: http://www.clinicaltrials.gov. Unique identifier: NCT00091637.
Morton J. Kern, MD seved as guest editor for this manuscript.
PII: S0002-8703(09)00726-1
doi:10.1016/j.ahj.2009.09.009
© 2009 Mosby, Inc. All rights reserved.
